VH Pharma SRL
VH Pharma reported total assets of 879,283 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jul 2026).
The score of VH Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +965 % Total assets +63 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
VH Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jul 2026
- Year ended 31 Dec 2024filed on 09 Jul 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
- Year ended 31 Dec 2022filed on 28 Aug 2023
VH Pharma's financial analysis
- Solvency26.9%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of VH Pharma
VH Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0788.292.373
- VAT number
- BE0788292373
- Peppol
- Registered · 0208:0788292373 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Jul 2022
- Registered office
- 2070 Beveren-Kruibeke-Zwijndrecht
- Latest accounts
- 2025 · filed on 15 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
VH Pharma (SRL) has been based in Beveren-Kruibeke-Zwijndrecht since 2022, active in: activities of holding companies. For 2025, it reports a net profit of 38,454 € and equity of 236,430 €; its revenue is not published. Its solvency stands at 26.9%, below the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to VH Pharma
Companies in the same business, of comparable size and area, outside its group.
- Invantri Activities of holding companies Antwerp · balance sheet 879,498 €
- SP Interieur Design Activities of holding companies Fleurus · balance sheet 879,563 €
- Sonora Invest Activities of holding companies Lommel · balance sheet 877,837 €
- Guinee Activities of holding companies Kapellen · balance sheet 881,069 €
- HX Holding Activities of holding companies Charleroi · balance sheet 877,280 €
- AL Bedrijfsadvies Activities of holding companies Zoersel · balance sheet 881,575 €
- V.B.G. Belgie Activities of holding companies Maaseik · balance sheet 876,938 €
- Lexas Activities of holding companies Boechout · balance sheet 875,914 €
Frequently asked questions about VH Pharma
What is the revenue of VH Pharma?
VH Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of VH Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0788292373 for VH Pharma, if the company is VAT-registered. Its company number (CBE) is 0788.292.373.
Where is the registered office of VH Pharma?
According to the CBE register, the registered office of VH Pharma is in 2070 Beveren-Kruibeke-Zwijndrecht.
What is the equity of VH Pharma?
At the close of the 2025 financial year, the equity of VH Pharma amounts to 236,430 €, a solvency of 26.9% of total assets.
Who manages VH Pharma?
The register lists 1 active mandates at VH Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of VH Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →